secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENZ Therapeutics, Inc. (LENZ)
CIK:        0001815776
Form:       8-K
Filed at:   2026-07-02T21:00:28+00:00
Accession:  0001815776-26-000046
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Zach Scheiner resigns from LENZ Therapeutics board; Jeff George appointed to audit committee
--------------------------------------------------------------------------------

- Zach Scheiner resigned from the Board and all committees effective June 30, 2026.
- Resignation was not due to any dispute or disagreement with the company.
- Board size reduced from seven to six members following the resignation.
- Jeff George appointed to Audit Committee; members now Thunen, Guerard, and George.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815776/000181577626000046/0001815776-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815776/000181577626000046/lenz-20260630.htm
  HTML page:      https://secwatch.observer/filing/0001815776-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer